Medical Microbiology articles for India

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 35

Article ‘Count’ for Medical Microbiology.

Journal Count Share
3 1.06
Combinatorial Synthesis of Next Generation Water‐Soluble Quaternized N‐Halamine Oligomers with Long‐Lasting Antiviral Properties 0.13
Host-Guest Inclusion Chemistry From Supramolecular Architecture Enabling Anti-Biofouling Surfaces for Oesophagus Stents 0.13
Nanoparticles‐Embedded Covalent Organic Framework Thin Films for Sequestrating Viral Pathogens 0.80
1 1.00
Synthesis of Glycolipid Library Reminiscent of Mycobacterial Cell Wall Motif A and Its Significance by Microscopy 1.00
4 0.93
<atl>Trends in Antifungal Resistance and Mechanistic Insights Into Azole Resistance in iCandida (candidozyma) auris/i : A 13-Year Study of a Comprehensive Set of Clinical Isolates From India</atl> 0.67
Health-related Quality of Life in European Older Adults with Respiratory Syncytial Virus Over Three Respiratory Syncytial Virus Seasons 0.09
Burden of Respiratory Syncytial Virus Among Older Adults With an Acute Respiratory Infection: A Prospective Study in Six European Countries 0.11
Kinetics and Predictors of Hepatitis B Surface Antigen (HBsAg) Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection 0.06
1 1.00
Genomic determinants across cross- and co-resistance events of the environmental resistome of Klebsiella pneumoniae 1.00
1 0.92
Microemulsion-Assisted Synthesis of Ni(II)-Grafted Cellulose Metallogel: Structural Insights into a High-Performance β-Lactamase Inhibitor 0.92
2 1.75
A secreted Leishmania metalloprotease manipulates host iron regulation by targeting the DICER1–miRNA pathway 1.00
SA-XV, a 15-amino acid fragment of host defense peptide S100A12, targets mitochondria and is protective against fungal infections 0.75
1 0.14
IL-32–producing CD8+ memory T cells define immunoregulatory niches in human cutaneous leishmaniasis 0.14
4 2.11
<atl>Safety and Immunogenicity of a Trivalent iSalmonella/i Conjugate Vaccine to iS./i Typhi, iS./i Typhimurium, and iS./i Enteritidis</atl> 0.25
High Seropositivity to rK39 and Capture of Leishmania-Infected Sand Flies in Bihar and Jharkhand Emphasize the Need for Post-Elimination Surveillance of Visceral Leishmaniasis in India 0.71
Essential Role of Clathrin and Lipid Rafts in pH-dependent Entry of Chandipura Virus: Independence From Caveolin Pathway 0.81
Human Metapneumovirus, Respiratory Syncytial Virus and Influenza Associated Pneumonia Hospitalizations in Colorado Adults Aged Over 50 Years: 2016-2023 0.33
7 5.46
Gut microbiome features associated with Bifidobacterium colonization predict personalized probiotic persistence patterns 0.71
Robust antibiotic sensitization of pathogenic Pseudomonas aeruginosa via negative hysteresis in the cell envelope 0.02
Spike conformational and glycan heterogeneity associated with furin cleavage causes incomplete neutralization of SARS-CoV-2 0.87
Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis 0.86
Fundamental role of spatial positioning of Mycobacterium tuberculosis in mycobacterial survival in macrophages 1.00
Cryo-EM structure of ribosome from pathogenic protozoa reveals unique features of its architecture 1.00
PfPPM2 signalling regulates asexual division and sexual conversion of human malaria parasite Plasmodium falciparum 1.00
2 1.20
A combination typhoid and non-typhoidal polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial 0.22
Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016–2020 0.98
1 1.00
Impeding pathways of intrinsic resistance in Escherichia coli confers antibiotic sensitization and resistance proofing 1.00
1 0.42
Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016–2019 0.42
1 0.01
SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting 0.01
2 1.02
Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial) 1.00
Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis 0.02
1 1.00
Protease-Mediated Shedding and Intermittent Mobility of the SARS-CoV-2 Delta Variant 1.00
1 0.20
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi 0.20
1 0.02
Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi 0.02
1 0.15
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine 0.15

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.